The concise, efficient synthesis of α-mangostin is described in eight simple steps with 8.3% overall yield. Highlights include a practical approach to construct the isopentene groups and other diverse groups at C-2 and C-8 of the xanthene skeleton through Claisen rearrangement and Wittig reaction. Meanwhile the first total synthesis of β-mangostin is presented with a similar approach.
Natural products provide the most important sources of lead compounds in drug discovery. Mangosteen (Garcinia mangostana Linn), belonging to the Guttiferae family, is the tropical fruit queen for its beneficial effects on human health. The fruit hull of mangosteen has been used as traditional medicine for the treatment of skin infections, wounds and diarrhea in Southeast Asia for many years [1] . α-Mangostin (1), β-mangostin (2) and dimethylmangostin (3) , isoprenylated xanthones isolated from mangosteen (Figure 1 ), show promising anticancer effects against a variety of cancer cell lines both in vitro and in vivo, such as human colon cancer (DLD-1, HT-29) [2] [3] , human prostate carcinoma PC-3 [4] , and breast cancer BC-1 [1, [5] [6] [7] . In addition, α-mangostin (1) and β-mangostin (2) were shown to inhibit the growth of Gram-positive pathogenic bacteria [8] . It is worth noting that α-mangostin (1) has a neuroprotective and cardioprotective effect by directly scavenging several ROS [9] [10] [11] . Reports also show that α -mangostin might be useful for either preventing or treating obesity through inhibiting fatty acid synthase (FAS) [12] . The significant biological activities of the mangostins have prompted many synthetic efforts toward this family of isoprenylated xanthones. In 1980, a construction of xanthone skeletons was described by Cotterill et al. [13] . After that, a total synthesis of two derivatives of mangostin was reported in 1981 [14] . In 2002, Iikubo et al. reported the first direct synthesis of α-mangostin [15] . However, the convergent synthesis was finished in 22 steps with an extremely low yield. Herein we report a radically different and efficient strategy for total synthesis of dimethylmangostin (3), α-mangostin (1) and β-mangostin (2). Dimethylmangostin (3), a natural molecule, is the key intermediate synthesized through a Claisen cyclization/ Claisen rearrangement/Wittig reaction pathway. Sequentially, α-mangostin (1) and β-mangostin (2) were generated via selective demethylation of 3. The efficient strategy can be adapted to the preparation of various analogs of the xanthone skeleton.
According to the initial synthesis strategy (Scheme 1), the key intermediate 5 was expected to be available by etherification of 11 at C1-OH and C7-OH for furnishing the required isopentenyl side chain. Then we envisioned that 5 would be converted to α-mangostin (1) and β-mangostin (2) through a hydrogenation/ Claisen rearrangement/demethylation pathway. In order to generate the desired 5, we treated 1 with 2-chloro-2-methylbutyne in the presence of K 2 CO 3 and KI [16] . Unfortunately, only compound 4 was obtained, in 65% yield, even when we used different bases and solvents. Because of the unsuccessful synthesis of key compound 5, a new synthetic strategy (Scheme 2) was proposed starting from 2, 4, 5-trimethoxybenzoyl acid (6) and 1, 3, 5-trimethoxybenzene (7) through Friedel-Crafts acylation to yield compound 9, which was subjected to cyclization without purification using NaOH in a refluxing mixture of MeOH and H 2 O to provide tetramethoxy mangostin 10 (87.3%) [13] . In the presence of HBr and AcOH by refluxing, dimethoxy mangostin 11 was obtained in 65% yield from compound 10 [13] .Treatment of 11 with allyl bromide, K 2 CO 3 , and KI in acetone at 60℃ afforded allyl ether 12 in 91.3% yield [16] .The ketone 13 was the key intermediate of this new synthetic strategy. In order to obtain compound 13, we tried many solvents such as dimethylbenzene, N, N-dimethylaniline and diphenyloxide. Finally N, N-dimethylaniline was identified to be suitable for this reaction and compound 13 was prepared in 87% yield [17] . The successful synthesis of 13 raised the possibility of constructing the isopentene groups at C-2 and C-8 of the xanthone skeleton.
With ketone 13 in hand, we initially expected to generate the corresponding aldehyde 16 by oxidative scission with either Pb(CH 3 COO) 4 or NaIO 4 (Scheme 3) . However, this failed to produce the desired epoxide of 13 with various oxidants such as either MCPBA or H 2 O 2 [18] [19] , and the dihydroxylation product with K 2 OsO 4 .2H 2 O [20] . Interestingly, exploration of oxidation reactions reported in the literature led us to realize that C 7 -OH of 13 probably was the important factor of the oxidation reaction. Thus, treatment of 13 with Me 2 SO 4 in acetone provided 7-hydroxy methylated product 14. Eventually, the desired aldehyde 15 was successfully obtained from 7-hydroxy methylated compound 14 via dihydroxylation with K 2 OsO 4 .2H 2 O, followed by oxidative scission of NaIO 4 [20] .
Next, a Wittig reaction between the unstable aldehyde 15 and isopropyltriphenylphosphonium bromide, using n-BuLi as base below 0 o C, gave dimethylmangostin (3) in 42.4% yield over two steps. Finally, in the presence of dimethylmangostin and NaCN in DMSO at 190-200 , -mangostin (2) and -mangostin (2) were smoothly accomplished in 61.3% and 24.8% yields, respectively [21] .
In this article, an economical approach to the synthesis of mangostin (1) and -mangostin (2) has been developed. Employing readily available reagents with short steps makes the present method superior to those reported earlier. A new synthetic method for dimethylmangostin (3) is only 7 steps with 13.5% overall yield, which makes it possible for its industrial production. Moreover, our strategy suits the synthesis of substantial amounts of a variety of analogs for investigation of biological activity and SAR studies. This strategy towards the synthesis of novel analogs of mangostins and their chemical and biological study is under progress and will be presented in due course. 
Experimental
General: All reactions sensitive to air or moisture were carried out under a nitrogen atmosphere in dry, freshly distilled solvents under anhydrous conditions, unless otherwise noted. Thin-layer chromatography (TLC) was performed on Merck silica gel plates (60 F 254 ) and visualized under UV light (254 nm). Column chromatography was performed using Merck Kieselgel 60 (230-400 mesh). Melting points were determined on a MEL-TEMP Ⅱ apparatus and are uncorrected. Infrared (IR) spectra were recorded on a Nicolet Impact 410 FT-IR spectrometer as KBr pellets. 1 H NMR and 13 C NMR spectra were recorded on a Bruker AV-300 MHz instrument in CDCl 3 using tetramethylsilane (TMS) as the internal standard. Electron impact mass spectra (EIMS) were recorded on a Shimadzu GC-MS 2050 apparatus. High-resolution mass spectra (HRMS) were recorded on a a Q-Tof Premier hybrid mass spectrometer using electron spray ionization (ESI).
1-Hydroxy-3, 6, 7-trimethoxy-8-(3-methylbut-2-en-1-yl)-2-(4methylpent-3-en-1-yl)-9H-xanthen-9-one (3) [22]
Step A: To a solution of 1-hydroxy-2, 8-diallyl-3, 6, 7-trimethoxy-9H-xanthen-9-one (14, 0.59 g, 0.0029 mol) in acetone (18 mL), H 2 O (6 mL) and tertiary butanol (6 mL), K 2 OsO 4 .2H 2 O was added (0.04 g, 0.0001 mol). The reaction mixture was stirred at room temperature for 1.5 h, then NaIO 4 (2.14 g, 0.01 mol) was added and the mixture stirred at room temperature for another 6 h. The solvent was removed and CH 2 Cl 2 (30 mL) was added to the residue. The resulting solution was washed by satd NaHSO 3 (2 × 20 mL) and H 2 O (2 × 20 mL), dried over Na 2 SO 4 and filtered. The filtrate was maintained and protected from light.
Step B: Isopropyltriphenylphosphonium bromide (0.37 g, 0.001 mol) was added to anhydrous THF (30 mL). After cooling to -10 , n-butyl lithium (3.0 mL of 2.4 M solution in n-hexane, 0.007 mol) was added to the solution. Then the mixture was protected from light and stirred at 28 for 2 h. After cooling to -10 , the filtrate obtained from step A was added to the reaction. The mixture was stirred at room temperature for 24 h and quenched by MeOH (2 mL). The solvent was removed under reduced pressure. CH 2 Cl 2 (40 mL) was added to the residue. The resulting solution was washed with H 2 O (3 × 20 mL) and dried over Na 2 SO 4. The crude product was chromatographed over silica gel (8:1 light petroleum/ethyl acetate) to give dimethylmangostin 3 (0.37 g) Yield: 42.4% over two steps as yellow solid.
Preparation of -mangostin and -mangostin Natural Product Communications Vol. 8 (8) 2013 1103 1, 3, 6-Trihydroxy-7-methoxy-2, 8-bis (3-methylbut-2-en-1-yl)-9H-xanthen-9-one (1) [23] and 1, 6-Dihydroxy-3, 7-dimethoxy-2, 8-bis (3-methylbut-2-en-1-yl)-9H-xanthen-9-one (2) [24] : To a stirred solution of 3 (0.30 g, 0.00068 mol) in DMSO (6.6 mL) was added NaCN (0.63 g, 0.013 mol). The mixture was heated to 190 for 4 h under a nitrogen atmosphere. After cooling to room temperature, the solution was poured into ice water (50 mL), and extracted with ethyl acetate (3 × 20 mL). The combined organic layers were washed with satd aq FeSO 4 (2 × 30 mL), H 2 O (30 mL), and brine (30 mL), and dried over Na 2 SO 4 . The crude product, chromatographed over silica gel (4:1 light petroleum/ethyl acetate), gave α-mangostin 1 (0.17 g) and β-mangostin 2 (0.07 g).
Structures of compounds 1-3 were identified conclusively by IR, MS and extensive 1 H and 13 C NMR spectral analysis and comparison with literature data.
